Jeevan Scientific Technology

Jeevan Scientific Technology Diluted EPS

The Diluted Earnings per Share of Jeevan Scientific Technology (538837.BO) as of Nov 12, 2026 is 0.58 INR. In the previous year, Diluted Earnings per Share was 0.07 INR — a change of 756.89% (higher).

Diluted EPS

0.58INR

YoY

756.89%

Last updated:

Diluted Earnings per Share of Jeevan Scientific Technology is 2026 0.58 INR. Diluted Earnings per Share of Jeevan Scientific Technology was 2025 0.07 INR. It decreases by 756.89% higher compared to the previous year.

The Jeevan Scientific Technology Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2019
0.56 INR
Jan 1, 2020
-4.31 INR
Jan 1, 2021
5.89 INR
Jan 1, 2022
6.16 INR
Jan 1, 2023
-1.53 INR
Jan 1, 2024
-0.65 INR
Jan 1, 2025
0.07 INR
Jan 1, 2026
0.58 INR
The Jeevan Scientific Technology Diluted EPS history
YEARDiluted EPSYoY
0.58INR+756.89%
0.07INR-110.36%
-0.65INR-57.60%
-1.53INR-124.93%
6.16INR+4.45%
5.89INR-236.74%
-4.31INR-870.74%
0.56INR+896.63%
0.06INR-94.23%
0.97INR-29,063.37%
-0.00INR-100.47%
0.72INR+531.61%
0.11INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jeevan Scientific Technology Stock analysis

What does Jeevan Scientific Technology do? Jeevan Scientific Technology Ltd generates revenue by providing global management consulting and technology services through its core segments of clinical research and information technology. The company leverages its expertise in outsourcing to support clients with a comprehensive suite of offerings, including clinical operations, bioanalytical research, and pathology laboratory services. These capabilities are structured to address specific needs within the pharmaceutical and healthcare sectors, ensuring robust support for complex scientific and regulatory requirements. The firm monetizes its clinical research services by delivering specialized solutions such as bioanalytical and bioequivalence studies, clinical trials, and trial management. Additional revenue streams are created through pharmacovigilance services, which encompass risk management plans and signal detection. The company also provides essential support functions like medical writing, clinical trial monitoring, drug safety management, and clinical data management, thereby offering end-to-end solutions for its clients. In the information technology segment, Jeevan Scientific Technology Ltd complements its scientific services with technical expertise in biostatistics, statistical programming, and quality assurance. By integrating these IT services with its clinical research capabilities, the company delivers a unified value proposition to its customer base. This integrated approach allows the firm to capture value across multiple touchpoints in the clinical development lifecycle, from initial study design to final data analysis and safety monitoring. Jeevan Scientific Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jeevan Scientific Technology stock

Diluted Earnings per Share of Jeevan Scientific Technology is 0.58 INR in 2026.

Diluted Earnings per Share of Jeevan Scientific Technology changed from 0.07 INR to 0.58 INR, representing a 756.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Jeevan Scientific Technology since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Jeevan Scientific Technology

All Key Metrics — Jeevan Scientific Technology